Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...
Kevin Nicusanti, Equity Funding Specialist at the Small Business and Technology Development Center, will de-mystify becoming investor-ready, understanding different types of investors, and how to ...
Patients who have hereditary angioedema, or HAE, can experience sudden and rapid swelling, often in the feet, hands, and abdomen. These unexpected attacks can also close off airways, potentially ...
Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm ...
Many facilities across North Carolina support life sciences research. The listing covers core laboratory facilities at university and nonprofit research institutions that are open to researchers or ...
Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...
There’s a new biotech company setting up shop in the Triangle, and it’s flush with cash and headed up by some big names in the industry. Meet Kriya Therapeutics – the brainchild of Dr. Shankar ...
Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form a North ...
SCHOTT Pharma USA, Inc., part of SHOTT Pharma AG, a global specialty glass manufacturer based in Germany, plans to invest $371 million over the next five years to build a new production facility in ...